ESTRO35 Programme Book
> Are the encouraging SABR results for NSCLC reproducible outside of pioneering academic institutions? C. Peedell (UK), E. Aynsley, D. Shakespeare, J. Green, P. Summers, J. Reynolds, K. Burke, H. Bayles, C. Huntley, N. Richmond > Changes in pulmonary function after single-fraction carbon-ion radiotherapy for stage I NSCLC W. Takahashi (Japan), N. Yamamoto, M. Nakajima, M. Karube, H. Yamashita, K. Nakagawa, H. Tsuji, T. Kamada > Radiotherapy as adjuvant or definitive treatment method in thymic tumours A. Napieralska (Poland), L. Miszczyk > Do higher doses of palliative radiotherapy still prolong survival in stage III/IV NSCLC? A. Price, K. MacLennan (UK), S. Campbell, S. Erridge, F. Little, T. Evans > Differential diagnosis between toxicity and recurrence after SBRT in early stage inoperable NSCLC R. Frakulli (Italy), F. Salvi, D. Balestrini, M. Palombarini, S. Cammelli, G. Macchia, M. Zompatori, A.G. Morganti, G. Frezza > Effect of overall treatment time in dose escalatation for radiotherapy of NSCLC. BED-time analysis J. Cabrera (Spain), A. Torres, A. Ruiz, A. Corbacho, M.A. Gonzalez, J. Quiros, F. Ropero, J. Muñoz > Salvage radiotherapy for locoregionally recurrent non-small cell lung cancer after resection E. Kim (Republic of Korea), J.S. Kim > Utilisation of new functional imaging in NSCLC radiotherapy: Can we use DW-MRI? M. Al Daly (Egypt), R. Hani, M. Fayec, S. Talima, H. Khafagy, M. Kmal, M. Hassan > Postoperative hypofractionated radiotherapy of non-small cell lung cancer: pattern of the relapses V.M. Sotnikov (Russian Federation), V.A. Solodkiy, V.M. Kcharchenko, G.A. Panshin, V.D. Chhikvadze, S.D. Trocenko, A.A. Morgunov
EP-1212
ELECTRONIC POSTERS
EP-1213
EP-1214
EP-1215
EP-1216
EP-1217
EP-1218
EP-1219
EP-1220
INTERDISCIPLINARY RADIOBIOLOGY
CLINICAL BRACHYTHERAPY PHYSICS
RTT
YOUNG
POSTERS AND ELECTRONIC POSTERS | PROGRAMME AND EXHIBITION GUIDE
232
Made with FlippingBook